US Bancorp’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.79M Buy
22,606
+1,701
+8% +$334K 0.01% 635
2026
Q1
$4.1M Sell
20,905
-1,559
-7% -$303K 0.01% 654
2025
Q4
$3.9M Sell
22,464
-302
-1% -$55K ﹤0.01% 672
2025
Q3
$4.34M Sell
22,766
-1,426
-6% -$253K 0.01% 648
2025
Q2
$4.35M Buy
24,192
+630
+3% +$109K 0.01% 638
2025
Q1
$3.99M Sell
23,562
-838
-3% -$138K 0.01% 636
2024
Q4
$3.68M Buy
24,400
+497
+2% +$77.3K ﹤0.01% 669
2024
Q3
$3.71M Sell
23,903
-211
-0.9% -$31.5K ﹤0.01% 666
2024
Q2
$3.3M Buy
24,114
+85
+0.4% +$11.6K ﹤0.01% 685
2024
Q1
$3.2M Buy
24,029
+313
+1% +$40.6K ﹤0.01% 700
2023
Q4
$3.27M Buy
23,716
+186
+0.8% +$24.5K ﹤0.01% 677
2023
Q3
$2.87M Sell
23,530
-790
-3% -$105K ﹤0.01% 687
2023
Q2
$3.42M Buy
24,320
+34
+0.1% +$4.69K 0.01% 645
2023
Q1
$3.44M Buy
24,286
+1,385
+6% +$198K 0.01% 644
2022
Q4
$3.58M Buy
22,901
+10,194
+80% +$1.46M 0.01% 628
2022
Q3
$1.56M Sell
12,707
-1,180
-8% -$155K ﹤0.01% 871
2022
Q2
$1.85M Buy
13,887
+307
+2% +$41.8K ﹤0.01% 841
2022
Q1
$1.86M Sell
13,580
-121
-0.9% -$16.9K ﹤0.01% 917
2021
Q4
$2.37M Sell
13,701
-474
-3% -$72.1K ﹤0.01% 850
2021
Q3
$2.06M Sell
14,175
-237
-2% -$34.7K ﹤0.01% 861
2021
Q2
$1.9M Buy
14,412
+139
+1% +$18.2K ﹤0.01% 900
2021
Q1
$1.83M Sell
14,273
-2,671
-16% -$329K ﹤0.01% 889
2020
Q4
$2.02M Sell
16,944
-1,778
-9% -$217K ﹤0.01% 807
2020
Q3
$2.14M Sell
18,722
-1,731
-8% -$205K 0.01% 722
2020
Q2
$2.33M Sell
20,453
-48
-0.2% -$5.09K 0.01% 682
2020
Q1
$1.65M Sell
20,501
-4,847
-19% -$502K 0.01% 730
2019
Q4
$2.71M Sell
25,348
-2,595
-9% -$271K 0.01% 674
2019
Q3
$2.99M Sell
27,943
-851
-3% -$87.4K 0.01% 636
2019
Q2
$2.93M Buy
28,794
+3,319
+13% +$319K 0.01% 658
2019
Q1
$2.29M Buy
25,475
+9,671
+61% +$838K 0.01% 713
2018
Q4
$1.31M Sell
15,804
-2,244
-12% -$210K ﹤0.01% 885
2018
Q3
$1.95M Sell
18,048
-452
-2% -$49.6K 0.01% 821
2018
Q2
$2.03M Sell
18,500
-76
-0.4% -$7.92K 0.01% 795
2018
Q1
$1.86M Buy
18,576
+125
+0.7% +$12.8K 0.01% 816
2017
Q4
$1.82M Buy
18,451
+531
+3% +$50.3K 0.01% 832
2017
Q3
$1.68M Sell
17,920
-145
-0.8% -$15.4K 0.01% 850
2017
Q2
$2.01M Buy
18,065
+156
+0.9% +$16.5K 0.01% 763
2017
Q1
$1.76M Buy
17,909
+1,608
+10% +$153K 0.01% 826
2016
Q4
$1.5M Sell
16,301
-662
-4% -$57.1K 0.01% 866
2016
Q3
$1.44M Sell
16,963
-1,396
-8% -$117K 0.01% 862
2016
Q2
$1.5M Sell
18,359
-3,543
-16% -$270K 0.01% 821
2016
Q1
$1.56M Sell
21,902
-12,560
-36% -$842K 0.01% 786
2015
Q4
$2.45M Sell
34,462
-6,073
-15% -$408K 0.01% 639
2015
Q3
$2.49M Buy
40,535
+2,933
+8% +$205K 0.01% 637
2015
Q2
$2.73M Sell
37,602
-4,051
-10% -$299K 0.01% 629
2015
Q1
$3.2M Sell
41,653
-684
-2% -$49K 0.01% 587
2014
Q4
$2.84M Buy
42,337
+1,056
+3% +$66.6K 0.01% 600
2014
Q3
$2.5M Sell
41,281
-259
-0.6% -$16K 0.01% 613
2014
Q2
$2.44M Sell
41,540
-1,499
-3% -$87.8K 0.01% 636
2014
Q1
$2.49M Buy
43,039
+12,549
+41% +$673K 0.01% 616
2013
Q4
$1.63M Buy
30,490
+2,470
+9% +$146K 0.01% 729
2013
Q3
$1.73M Sell
28,020
-2,271
-7% -$136K 0.01% 683
2013
Q2
$1.84M Buy
+30,291
New +$1.8M 0.01% 629

Other funds holding DGX

US Bancorp's DGX Position: Q2 2026 in Review

US Bancorp increased its Quest Diagnostics (DGX) stake by 8.1% in Q2 2026, buying an estimated $334K and bringing the position to 22,606 shares worth $4.79M. The position accounts for 0.01% of the portfolio, ranked #635.

US Bancorp first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • US Bancorp held 22,606 shares of Quest Diagnostics worth $4.79M as of Q2 2026.
  • US Bancorp bought 1,701 Quest Diagnostics shares in Q2 2026, an estimated $334K.
  • Quest Diagnostics made up 0.01% of US Bancorp's portfolio in Q2 2026, its #635 holding.
  • US Bancorp first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.